StockData
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

Canopy Growth Corp

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72+0.00 (+0.38%)

Close on Oct 19, 2026

Earnings

Next report expected Nov 6, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2027
Ended Jun 30, 2026
Aug 7, 2026Before market open$81.20M$-0.03–
Q4 FY2026
Ended Mar 31, 2026
Jun 15, 2026Before market open$71.20M$-0.40–
Q3 FY2026
Ended Dec 31, 2025
Feb 6, 2026Before market open$75.00M––
Q2 FY2026
Ended Sep 30, 2025
Nov 7, 2025Before market open$67.00M$-0.01–
Q1 FY2026
Ended Jun 30, 2025
Aug 8, 2025Before market open–$-0.22–
Q4 FY2025
Ended Mar 31, 2025
May 30, 2025Before market open$65.03M$-1.43–
Q3 FY2025
Ended Dec 31, 2024
Feb 7, 2025Before market open$74.76M$-1.11–
Q2 FY2025
Ended Sep 30, 2024
Nov 8, 2024Before market open–––
Q1 FY2025
Ended Jun 30, 2024
Aug 9, 2024Before market open$66.00M$-1.60–
Q4 FY2024
Ended Mar 31, 2024
May 30, 2024Before market open$72.80M$-1.03–
Q3 FY2024
Ended Dec 31, 2023
Feb 9, 2024Before market open$79.00M$-2.62–

Press releases

Announcements Canopy Growth filed with the SEC